United States Biologics and Biosimilars Market Report 2017

United States Biologics and Biosimilars Market Report 2017

1 Biologics and Biosimilars Overview

1.1 Product Overview and Scope of Biologics and Biosimilars

1.2 Classification of Biologics and Biosimilars by Product Category

1.2.1 United States Biologics and Biosimilars Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Biologics and Biosimilars Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Antibiotic

1.2.4 Enzyme

1.2.5 Hormone

1.2.6 Non-Patented Biological Reagents

1.2.7 Other

1.3 United States Biologics and Biosimilars Market by Application/End Users

1.3.1 United States Biologics and Biosimilars Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Other

1.4 United States Biologics and Biosimilars Market by Region

1.4.1 United States Biologics and Biosimilars Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Biologics and Biosimilars Status and Prospect (2012-2022)

1.4.3 Southwest Biologics and Biosimilars Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Biologics and Biosimilars Status and Prospect (2012-2022)

1.4.5 New England Biologics and Biosimilars Status and Prospect (2012-2022)

1.4.6 The South Biologics and Biosimilars Status and Prospect (2012-2022)

1.4.7 The Midwest Biologics and Biosimilars Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Biologics and Biosimilars (2012-2022)

1.5.1 United States Biologics and Biosimilars Sales and Growth Rate (2012-2022)

1.5.2 United States Biologics and Biosimilars Revenue and Growth Rate (2012-2022)

2 United States Biologics and Biosimilars Market Competition by Players/Suppliers

2.1 United States Biologics and Biosimilars Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Biologics and Biosimilars Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Biologics and Biosimilars Average Price by Players/Suppliers (2012-2017)

2.4 United States Biologics and Biosimilars Market Competitive Situation and Trends

2.4.1 United States Biologics and Biosimilars Market Concentration Rate

2.4.2 United States Biologics and Biosimilars Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Biologics and Biosimilars Manufacturing Base Distribution, Sales Area, Product Type

3 United States Biologics and Biosimilars Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Biologics and Biosimilars Sales and Market Share by Region (2012-2017)

3.2 United States Biologics and Biosimilars Revenue and Market Share by Region (2012-2017)

3.3 United States Biologics and Biosimilars Price by Region (2012-2017)

4 United States Biologics and Biosimilars Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Biologics and Biosimilars Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)

4.3 United States Biologics and Biosimilars Price by Type (2012-2017)

4.4 United States Biologics and Biosimilars Sales Growth Rate by Type (2012-2017)

5 United States Biologics and Biosimilars Sales (Volume) by Application (2012-2017)

5.1 United States Biologics and Biosimilars Sales and Market Share by Application (2012-2017)

5.2 United States Biologics and Biosimilars Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Biologics and Biosimilars Players/Suppliers Profiles and Sales Data

6.1 Pfizer

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Biologics and Biosimilars Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Roche

6.2.2 Biologics and Biosimilars Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Amgen

6.3.2 Biologics and Biosimilars Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 AbbVie

6.4.2 Biologics and Biosimilars Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Sanofi

6.5.2 Biologics and Biosimilars Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Johnson & Johnson

6.6.2 Biologics and Biosimilars Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Novo Nordisk

6.7.2 Biologics and Biosimilars Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Novartis

6.8.2 Biologics and Biosimilars Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Merck

6.9.2 Biologics and Biosimilars Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Lilly

6.10.2 Biologics and Biosimilars Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 3sbio

6.12 Changchun High Tech

6.13 CP Guojian Pharmacy

6.14 Biotech Pharma

6.15 Gelgen Biopharma

6.16 Sandoz

6.17 Teva

6.18 Hospira

6.19 Mylan

7 Biologics and Biosimilars Manufacturing Cost Analysis

7.1 Biologics and Biosimilars Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Biologics and Biosimilars

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Biologics and Biosimilars Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Biologics and Biosimilars Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Biologics and Biosimilars Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Biologics and Biosimilars Sales Volume Forecast by Type (2017-2022)

11.3 United States Biologics and Biosimilars Sales Volume Forecast by Application (2017-2022)

11.4 United States Biologics and Biosimilars Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Biologics and Biosimilars

Figure United States Biologics and Biosimilars Market Size (K Units) by Type (2012-2022)

Figure United States Biologics and Biosimilars Sales Volume Market Share by Type (Product Category) in 2016

Figure Antibiotic Product Picture

Figure Enzyme Product Picture

Figure Hormone Product Picture

Figure Non-Patented Biological Reagents Product Picture

Figure Other Product Picture

Figure United States Biologics and Biosimilars Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Biologics and Biosimilars by Application in 2016

Figure Tumor Examples

Table Key Downstream Customer in Tumor

Figure Diabetes Examples

Table Key Downstream Customer in Diabetes

Figure Cardiovascular Examples

Table Key Downstream Customer in Cardiovascular

Figure Hemophilia Examples

Table Key Downstream Customer in Hemophilia

Figure Other Examples

Table Key Downstream Customer in Other

Figure United States Biologics and Biosimilars Market Size (Million USD) by Region (2012-2022)

Figure The West Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Biologics and Biosimilars Sales (K Units) and Growth Rate (2012-2022)

Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Biologics and Biosimilars Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Biologics and Biosimilars Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Biologics and Biosimilars Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Biologics and Biosimilars Sales Share by Players/Suppliers

Figure 2017 United States Biologics and Biosimilars Sales Share by Players/Suppliers

Figure United States Biologics and Biosimilars Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Biologics and Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Biologics and Biosimilars Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Biologics and Biosimilars Revenue Share by Players/Suppliers

Figure 2017 United States Biologics and Biosimilars Revenue Share by Players/Suppliers

Table United States Market Biologics and Biosimilars Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Biologics and Biosimilars Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Biologics and Biosimilars Market Share of Top 3 Players/Suppliers

Figure United States Biologics and Biosimilars Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Biologics and Biosimilars Product Category

Table United States Biologics and Biosimilars Sales (K Units) by Region (2012-2017)

Table United States Biologics and Biosimilars Sales Share by Region (2012-2017)

Figure United States Biologics and Biosimilars Sales Share by Region (2012-2017)

Figure United States Biologics and Biosimilars Sales Market Share by Region in 2016

Table United States Biologics and Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Biologics and Biosimilars Revenue Share by Region (2012-2017)

Figure United States Biologics and Biosimilars Revenue Market Share by Region (2012-2017)

Figure United States Biologics and Biosimilars Revenue Market Share by Region in 2016

Table United States Biologics and Biosimilars Price (USD/Unit) by Region (2012-2017)

Table United States Biologics and Biosimilars Sales (K Units) by Type (2012-2017)

Table United States Biologics and Biosimilars Sales Share by Type (2012-2017)

Figure United States Biologics and Biosimilars Sales Share by Type (2012-2017)

Figure United States Biologics and Biosimilars Sales Market Share by Type in 2016

Table United States Biologics and Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Biologics and Biosimilars Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Biologics and Biosimilars by Type (2012-2017)

Figure Revenue Market Share of Biologics and Biosimilars by Type in 2016

Table United States Biologics and Biosimilars Price (USD/Unit) by Types (2012-2017)

Figure United States Biologics and Biosimilars Sales Growth Rate by Type (2012-2017)

Table United States Biologics and Biosimilars Sales (K Units) by Application (2012-2017)

Table United States Biologics and Biosimilars Sales Market Share by Application (2012-2017)

Figure United States Biologics and Biosimilars Sales Market Share by Application (2012-2017)

Figure United States Biologics and Biosimilars Sales Market Share by Application in 2016

Table United States Biologics and Biosimilars Sales Growth Rate by Application (2012-2017)

Figure United States Biologics and Biosimilars Sales Growth Rate by Application (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Pfizer Biologics and Biosimilars Sales Growth Rate (2012-2017)

Figure Pfizer Biologics and Biosimilars Sales Market Share in United States (2012-2017)

Figure Pfizer Biologics and Biosimilars Revenue Market Share in United States (2012-2017)

Table Roche Basic Information List

Table Roche Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Roche Biologics and Biosimilars Sales Growth Rate (2012-2017)

Figure Roche Biologics and Biosimilars Sales Market Share in United States (2012-2017)

Figure Roche Biologics and Biosimilars Revenue Market Share in United States (2012-2017)

Table Amgen Basic Information List

Table Amgen Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Amgen Biologics and Biosimilars Sales Growth Rate (2012-2017)

Figure Amgen Biologics and Biosimilars Sales Market Share in United States (2012-2017)

Figure Amgen Biologics and Biosimilars Revenue Market Share in United States (2012-2017)

Table AbbVie Basic Information List

Table AbbVie Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure AbbVie Biologics and Biosimilars Sales Growth Rate (2012-2017)

Figure AbbVie Biologics and Biosimilars Sales Market Share in United States (2012-2017)

Figure AbbVie Biologics and Biosimilars Revenue Market Share in United States (2012-2017)

Table Sanofi Basic Information List

Table Sanofi Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Sanofi Biologics and Biosimilars Sales Growth Rate (2012-2017)

Figure Sanofi Biologics and Biosimilars Sales Market Share in United States (2012-2017)

Figure Sanofi Biologics and Biosimilars Revenue Market Share in United States (2012-2017)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Johnson & Johnson Biologics and Biosimilars Sales Growth Rate (2012-2017)

Figure Johnson & Johnson Biologics and Biosimilars Sales Market Share in United States (2012-2017)

Figure Johnson & Johnson Biologics and Biosimilars Revenue Market Share in United States (2012-2017)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Novo Nordisk Biologics and Biosimilars Sales Growth Rate (2012-2017)

Figure Novo Nordisk Biologics and Biosimilars Sales Market Share in United States (2012-2017)

Figure Novo Nordisk Biologics and Biosimilars Revenue Market Share in United States (2012-2017)

Table Novartis Basic Information List

Table Novartis Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Novartis Biologics and Biosimilars Sales Growth Rate (2012-2017)

Figure Novartis Biologics and Biosimilars Sales Market Share in United States (2012-2017)

Figure Novartis Biologics and Biosimilars Revenue Market Share in United States (2012-2017)

Table Merck Basic Information List

Table Merck Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Merck Biologics and Biosimilars Sales Growth Rate (2012-2017)

Figure Merck Biologics and Biosimilars Sales Market Share in United States (2012-2017)

Figure Merck Biologics and Biosimilars Revenue Market Share in United States (2012-2017)

Table Lilly Basic Information List

Table Lilly Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Lilly Biologics and Biosimilars Sales Growth Rate (2012-2017)

Figure Lilly Biologics and Biosimilars Sales Market Share in United States (2012-2017)

Figure Lilly Biologics and Biosimilars Revenue Market Share in United States (2012-2017)

Table 3sbio Basic Information List

Table Changchun High Tech Basic Information List

Table CP Guojian Pharmacy Basic Information List

Table Biotech Pharma Basic Information List

Table Gelgen Biopharma Basic Information List

Table Sandoz Basic Information List

Table Teva Basic Information List

Table Hospira Basic Information List

Table Mylan Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biologics and Biosimilars

Figure Manufacturing Process Analysis of Biologics and Biosimilars

Figure Biologics and Biosimilars Industrial Chain Analysis

Table Raw Materials Sources of Biologics and Biosimilars Major Players/Suppliers in 2016

Table Major Buyers of Biologics and Biosimilars

Table Distributors/Traders List

Figure United States Biologics and Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Biologics and Biosimilars Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Type in 2022

Table United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Application in 2022

Table United States Biologics and Biosimilars Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Biologics and Biosimilars Sales Volume Share Forecast by Region (2017-2022)

Figure United States Biologics and Biosimilars Sales Volume Share Forecast by Region (2017-2022)

Figure United States Biologics and Biosimilars Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources